Medicare Enrolled

Dr. Emmanuel Chang, MD/PHD

Retina Specialist (Ophthalmology) Physician · Bellaire, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
6565 WEST LOOP S STE 400, Bellaire, TX 77401
7137999975
In practice since 2008 (17 years)
NPI: 1083877740 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chang? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chang

Dr. Emmanuel Chang is a retina specialist (ophthalmology) physician in Bellaire, TX, with 17 years in practice. Based on federal Medicare data, Dr. Chang performed 50,533 Medicare services across 3,058 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chang received a total of $255,870 from 23 pharmaceutical and/or device companies across 393 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in retina specialist (ophthalmology) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chang is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 3% volume in TX$ $255,870 industry payments

Medicare Practice Summary

Medicare Utilization ↗
50,533
Medicare services
Top 3% in TX for retina specialist (ophthalmology) physician
3,058
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,973 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Eye injection (Vabysmo/faricimab)43,560$29$93
Retinal imaging (OCT scan)1,650$30$100
Office visit, established patient (30-39 min)1,230$85$318
Extended exam of the back part of the eye with optic nerve drawing924$12$39
Eye injection for retinal disease893$99$333
Aflibercept eye injection (Eylea)758$685$987
Extended exam of the back part of the eye with retinal drawing395$19$62
Comprehensive eye exam, established patient257$98$312
Injection, ranibizumab, 0.1 mg240$188$413
2d ultrasound scan of eye tissue and structures210$36$112
Exam of retinal blood vessels using a special camera after injection of a dye142$97$336
New patient office visit (45-59 min)89$115$418
Retinal photography (fundus photo)54$28$93
Injection, bevacizumab, 10 mg54$56$85
Office visit, established patient, complex (40-54 min)30$124$456
Complex repair of detached retina and drainage of eye fluid between lens and retina17$1,047$3,381
New patient office visit, complex (60-74 min)17$151$554
Exam of retinal blood vessels and blood vessels between the white part of eye and retina using a special camera after injection of a dye13$195$666
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$255,870
Total received (2018-2024)
Avg $36,553/year across 7 years
Top 6% in TX for retina specialist (ophthalmology) physician
23
Companies
393
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$179,679 (70.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$68,165 (26.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,840 (2.3%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$2,185 (0.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$53,206
2023
$37,055
2022
$54,317
2021
$35,914
2020
$12,940
2019
$22,889
2018
$39,549

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Genentech USA, Inc.
$151,715
Bausch & Lomb Americas Inc.
$33,199
Regeneron Healthcare Solutions, Inc.
$26,481
Novartis Pharmaceuticals Corporation
$20,044
Bausch & Lomb, a division of Bausch Health US, LLC
$8,954
Allergan Inc.
$6,430
Regeneron Pharmaceuticals, Inc.
$3,986
US Retina LLC
$2,185
Genentech, Inc.
$523
Apellis Pharmaceuticals, Inc.
$368
AbbVie Inc.
$298
OPTOS, INC.
$245
Harrow Eye, LLC
$227
Biogen, Inc.
$200
Astellas Pharma US Inc
$184
EyePoint Pharmaceuticals US, Inc.
$183
Allergan, Inc.
$165
Sun Pharmaceutical Industries Inc.
$149
Alcon Vision LLC
$100
Oculus Surgical Inc.
$87
Carl Zeiss Meditec, Inc.
$70
Alimera Sciences, Inc.
$38
Dutch Ophthalmic, USA
$38
Top 3 companies account for 82.6% of total payments
Associated products mentioned in payments ›
BEOVU · BROMSITE · BYOOVIZ · BromSite (bromfenac ophthalmic solution) 0.075% · Constellation · DEXYCU · DUREZOL · EVA · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · IHEEZO · ILUVIEN · Iluvien · Izervay · LOTEMAX SM · Lucentis · Monaco · OZURDEX · P200DTx · STELLARIS · SUSVIMO · Stellaris · Susvimo · Syfovre · VABYSMO · VISUDYNE · VITESSE · Vabysmo · XIPERE · YUTIQ · combined machine
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (70%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in retina specialist (ophthalmology) physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for retina specialist (ophthalmology) physician in TX.

Equivalent to $506 per 100 Medicare services performed
Looking for a retina specialist (ophthalmology) physician in Bellaire?
Compare retina specialist (ophthalmology) physicians in the Bellaire area by procedure volume, costs, and industry payment transparency.
Browse retina specialist (ophthalmology) physicians nearby

Geographic Context

Retina Specialist (Ophthalmology) Physicians within 10 mi
19
Per 100K population
0.4
County median income
$73,104
Nearest hospital
BEHAVIORAL HOSPITAL OF BELLAIRE
1.2 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Chang is a mixed practice specialist, with above-average Medicare volume (top 3% in TX), and high industry engagement (speaking/promotional, top 6%), with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Chang experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Chang performed 43,560 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chang receive payments from pharmaceutical companies?
Yes. Dr. Chang received a total of $255,870 from 23 companies across 393 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chang's costs compare to other retina specialist (ophthalmology) physicians in Bellaire?
Dr. Chang's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →